Cargando…

Origin and evolution of SARS-CoV-2

SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagani, Isabel, Ghezzi, Silvia, Alberti, Simone, Poli, Guido, Vicenzi, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933829/
https://www.ncbi.nlm.nih.gov/pubmed/36811098
http://dx.doi.org/10.1140/epjp/s13360-023-03719-6
_version_ 1784889754188251136
author Pagani, Isabel
Ghezzi, Silvia
Alberti, Simone
Poli, Guido
Vicenzi, Elisa
author_facet Pagani, Isabel
Ghezzi, Silvia
Alberti, Simone
Poli, Guido
Vicenzi, Elisa
author_sort Pagani, Isabel
collection PubMed
description SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS), has a zoonotic origin, although SARS-CoV-2 precise chain of animal-to-human transmission remains undefined. Unlike the 2002–2003 pandemic caused by SARS-CoV whose extinction from the human population was achieved in eight months, SARS-CoV-2 has been spreading globally in an immunologically naïve population in an unprecedented manner. The efficient infection and replication of SARS-CoV-2 has resulted in the emergence of viral variants that have become predominant posing concerns about their containment as they are more infectious with variable pathogenicity in respect to the original virus. Although vaccine availability is limiting severe disease and death caused by SARS-CoV-2 infection, its extinction is far to be close and predictable. In this regard, the emersion of the Omicron viral variant in November 2021 was characterized by humoral immune escape and it has reinforced the importance of the global monitoring of SARS-CoV-2 evolution. Given the importance of the SARS-CoV-2 zoonotic origin, it will also be crucial to monitor the animal-human interface to be better prepared to cope with future infections of pandemic potential.
format Online
Article
Text
id pubmed-9933829
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99338292023-02-17 Origin and evolution of SARS-CoV-2 Pagani, Isabel Ghezzi, Silvia Alberti, Simone Poli, Guido Vicenzi, Elisa Eur Phys J Plus Review SARS-CoV-2 is a novel coronavirus that emerged in China at the end of 2019 causing the severe disease known as coronavirus disease 2019 (COVID-19). SARS-CoV-2, as to the previously highly pathogenic human coronaviruses named SARS-CoV, the etiological agent of severe acute respiratory syndrome (SARS), has a zoonotic origin, although SARS-CoV-2 precise chain of animal-to-human transmission remains undefined. Unlike the 2002–2003 pandemic caused by SARS-CoV whose extinction from the human population was achieved in eight months, SARS-CoV-2 has been spreading globally in an immunologically naïve population in an unprecedented manner. The efficient infection and replication of SARS-CoV-2 has resulted in the emergence of viral variants that have become predominant posing concerns about their containment as they are more infectious with variable pathogenicity in respect to the original virus. Although vaccine availability is limiting severe disease and death caused by SARS-CoV-2 infection, its extinction is far to be close and predictable. In this regard, the emersion of the Omicron viral variant in November 2021 was characterized by humoral immune escape and it has reinforced the importance of the global monitoring of SARS-CoV-2 evolution. Given the importance of the SARS-CoV-2 zoonotic origin, it will also be crucial to monitor the animal-human interface to be better prepared to cope with future infections of pandemic potential. Springer Berlin Heidelberg 2023-02-16 2023 /pmc/articles/PMC9933829/ /pubmed/36811098 http://dx.doi.org/10.1140/epjp/s13360-023-03719-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Pagani, Isabel
Ghezzi, Silvia
Alberti, Simone
Poli, Guido
Vicenzi, Elisa
Origin and evolution of SARS-CoV-2
title Origin and evolution of SARS-CoV-2
title_full Origin and evolution of SARS-CoV-2
title_fullStr Origin and evolution of SARS-CoV-2
title_full_unstemmed Origin and evolution of SARS-CoV-2
title_short Origin and evolution of SARS-CoV-2
title_sort origin and evolution of sars-cov-2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933829/
https://www.ncbi.nlm.nih.gov/pubmed/36811098
http://dx.doi.org/10.1140/epjp/s13360-023-03719-6
work_keys_str_mv AT paganiisabel originandevolutionofsarscov2
AT ghezzisilvia originandevolutionofsarscov2
AT albertisimone originandevolutionofsarscov2
AT poliguido originandevolutionofsarscov2
AT vicenzielisa originandevolutionofsarscov2